264 results on '"Yura, K."'
Search Results
2. Time-varying overdispersion of SARS-CoV-2 transmission during the periods when different variants of concern were circulating in Japan
- Author
-
Yura K. Ko, Yuki Furuse, Kanako Otani, Masato Yamauchi, Kota Ninomiya, Mayuko Saito, Takeaki Imamura, Alex R. Cook, Tadayuki Ahiko, Shunji Fujii, Yoshiharu Mori, Emiko Suzuki, Keiko Yamada, Yoshikazu Ashino, Hidetoshi Yamashita, Yuichi Kato, Katsumi Mizuta, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
Medicine ,Science - Abstract
Abstract Japan has implemented a cluster-based approach for coronavirus disease 2019 (COVID-19) from the pandemic’s beginning based on the transmission heterogeneity (overdispersion) of severe acute respiratory coronavirus 2 (SARS-CoV-2). However, studies analyzing overdispersion of transmission among new variants of concerns (VOCs), especially for Omicron, were limited. Thus, we aimed to clarify how the transmission heterogeneity has changed with the emergence of VOCs (Alpha, Delta, and Omicron) using detailed contact tracing data in Yamagata Prefecture, Japan. We estimated the time-varying dispersion parameter ( $${k}_{t}$$ k t ) by fitting a negative binomial distribution for each transmission generation. Our results showed that even after the emergence of VOCs, there was transmission heterogeneity of SARS-CoV-2, with changes in $${k}_{t}$$ k t during each wave. Continuous monitoring of transmission dynamics is vital for implementing appropriate measures. However, a feasible and sustainable epidemiological analysis system should be established to make this possible.
- Published
- 2023
- Full Text
- View/download PDF
3. SARS-CoV-2 Variants and Age-Dependent Infection Rates among Household and Nonhousehold Contacts
- Author
-
Reiko Miyahara, Kosuke Tamura, Tomoko Kato, Mineko Nakazaki, Kanako Otani, Yura K. Ko, Taro Kamigaki, Yuzo Arima, Hideki Tani, Kazunori Oishi, and Motoi Suzuki
- Subjects
COVID-19 ,2019 novel coronavirus disease ,coronavirus disease ,severe acute respiratory syndrome coronavirus 2 ,SARS-CoV-2 ,viruses ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
To determine the effects of age and variants of concern on transmission of SARS-CoV-2, we analyzed infection rates among close contacts over 4 periods in Toyama Prefecture, Japan. Among household contacts, odds of infection were 6.2 times higher during the period of the Omicron variant than during previous periods, particularly among children and adolescents.
- Published
- 2023
- Full Text
- View/download PDF
4. Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan
- Author
-
Ko, Yura K., Murayama, Hiroaki, Yamasaki, Lisa, Kinoshita, Ryo, Suzuki, Motoi, and Nishiura, Hiroshi
- Subjects
Age factors in disease -- Analysis ,Health - Abstract
Since the emergence of SARS-CoV-2 in Japan, COVID-19 has remained a substantial public health concern. As of September 1, 2021, the cumulative number of reported cases in Japan had reached [...]
- Published
- 2022
- Full Text
- View/download PDF
5. Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan
- Author
-
Yura K. Ko, Hiroaki Murayama, Lisa Yamasaki, Ryo Kinoshita, Motoi Suzuki, and Hiroshi Nishiura
- Subjects
COVID-19 ,2019 novel coronavirus disease ,coronavirus disease ,severe acute respiratory syndrome coronavirus 2 ,SARS-CoV-2 ,viruses ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
COVID-19 vaccine effectiveness against death in Japan remains unknown. Furthermore, although evidence indicates that healthcare capacity influences case-fatality risk (CFR), it remains unknown whether this relationship is mediated by age. With a modeling study, we analyzed daily COVID-19 cases and deaths during January–August 2021 by using Tokyo surveillance data to jointly estimate COVID-19 vaccine effectiveness against death and age-specific CFR. We also examined daily healthcare operations to determine the association between healthcare burden and age-specific CFR. Among fully vaccinated patients, vaccine effectiveness against death was 88.6% among patients 60–69 years of age, 83.9% among patients 70–79 years of age, 83.5% among patients 80–89 years of age, and 77.7% among patients >90 years of age. A positive association of several indicators of healthcare burden with CFR among patients >70 years of age suggested an age-dependent effect of healthcare burden on CFR in Japan.
- Published
- 2022
- Full Text
- View/download PDF
6. Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan
- Author
-
Kayano, Taishi, Sasanami, Misaki, Kobayashi, Tetsuro, Ko, Yura K., Otani, Kanako, Suzuki, Motoi, and Nishiura, Hiroshi
- Published
- 2022
- Full Text
- View/download PDF
7. Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion
- Author
-
Yura K Ko, Yuki Furuse, Kota Ninomiya, Kanako Otani, Hiroki Akaba, Reiko Miyahara, Tadatsugu Imamura, Takeaki Imamura, Alex R Cook, Mayuko Saito, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
COVID-19 ,Secondary transmission ,Super-spreading events ,Overdispersion ,Dispersion parameter ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: Super-spreading events caused by overdispersed secondary transmission are crucial in the transmission of COVID-19. However, the exact level of overdispersion, demographics, and other factors associated with secondary transmission remain elusive. In this study, we aimed to elucidate the frequency and patterns of secondary transmission of SARS-CoV-2 in Japan. Methods: We analyzed 16,471 cases between January 2020 and August 2020. We generated the number of secondary cases distribution and estimated the dispersion parameter (k) by fitting the negative binomial distribution in each phase. The frequencies of the secondary transmission were compared by demographic and clinical characteristics, calculating the odds ratio using logistic regression models. Results: We observed that 76.7% of the primary cases did not generate secondary cases with an estimated dispersion parameter k of 0.23. The demographic patterns of primary-secondary cases differed between phases, with 20–69 years being the predominant age group. There were higher proportions of secondary transmissions among older individuals, symptomatic patients, and patients with 2 days or more between onset and confirmation. Conclusions: The study showed the estimation of the frequency of secondary transmission of SARS-CoV-2 and the characteristics of people who generated the secondary transmission.
- Published
- 2022
- Full Text
- View/download PDF
8. Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion
- Author
-
Ko, Yura K, Furuse, Yuki, Ninomiya, Kota, Otani, Kanako, Akaba, Hiroki, Miyahara, Reiko, Imamura, Tadatsugu, Imamura, Takeaki, Cook, Alex R, Saito, Mayuko, Suzuki, Motoi, and Oshitani, Hitoshi
- Published
- 2022
- Full Text
- View/download PDF
9. Unraveling the indirect effects of interventions against malaria endemicity: A systematic scoping review
- Author
-
Ko, Yura K, primary, Kagaya, Wataru, additional, Chan, Chim W, additional, Kanamori, Mariko, additional, Mbugua, Samuel, additional, Rotich, Alex, additional, Kanoi, Bernard, additional, Ngara, Mtakai, additional, Gitaka, Jesse, additional, and Kaneko, Akira, additional
- Published
- 2024
- Full Text
- View/download PDF
10. Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan
- Author
-
Taishi Kayano, Misaki Sasanami, Tetsuro Kobayashi, Yura K. Ko, Kanako Otani, Motoi Suzuki, and Hiroshi Nishiura
- Subjects
Averted burden ,COVID-19 ,Statistical model ,Vaccination ,Epidemiology ,Direct effectiveness ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: In Japan, vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initiated on 17 February 2021, mainly using messenger RNA vaccines and prioritizing health care professionals. Whereas nationwide vaccination alleviated the coronavirus disease 2019 (COVID-19)-related burden, the population impact has yet to be quantified in Japan. We aimed to estimate the numbers of COVID-19 cases and deaths prevented that were attributable to the reduced risk among vaccinated individuals via a statistical modeling framework. Methods: We analyzed confirmed cases registered in the Health Center Real-time Information-sharing System on COVID-19 (3 March–30 November 2021) and publicly reported COVID-19-related deaths (24 March–30 November 2021). The vaccination coverage over this time course, classified by age and sex, was extracted from vaccine registration systems. The total numbers of prevented cases and deaths were calculated by multiplying the daily risk differences between unvaccinated and vaccinated individuals by the population size of vaccinated individuals. Findings: For both cases and deaths, the averted numbers were estimated to be the highest among individuals aged 65 years and older. In total, we estimated that 564,596 (95% confidence interval: 477,020–657,525) COVID-19 cases and 18,622 (95% confidence interval: 6522–33,762) deaths associated with SARS-CoV-2 infection were prevented owing to vaccination during the analysis period (i.e., fifth epidemic wave, caused mainly by the Delta variant). Female individuals were more likely to be protected from infection following vaccination than male individuals whereas more deaths were prevented in male than in female individuals. Interpretation: The vaccination program in Japan led to substantial reductions in the numbers of COVID-19 cases and deaths (33% and 67%, respectively). The preventive effect will be further amplified during future pandemic waves caused by variants with shared antigenicity. Funding: This project was supported by the Japan Science and Technology Agency; the Japan Agency for Medical Research and Development; the Japan Society for the Promotion of Science; and the Ministry of Health, Labour and Welfare.
- Published
- 2022
- Full Text
- View/download PDF
11. Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February−May 2020
- Author
-
Reiko Miyahara, Naho Tsuchiya, Ikkoh Yasuda, Yura K. Ko, Yuki Furuse, Eiichiro Sando, Shohei Nagata, Tadatsugu Imamura, Mayuko Saito, Konosuke Morimoto, Takeaki Imamura, Yugo Shobugawa, Hiroshi Nishiura, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
coronavirus disease ,COVID-19 ,respiratory infections ,familial clusters ,prefectures ,Japan ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
The overall coronavirus disease secondary attack rate (SAR) in family members was 19.0% in 10 prefectures of Japan during February 22–May 31, 2020. The SAR was lower for primary cases diagnosed early, within 2 days after symptom onset. The SAR of asymptomatic primary cases was 11.8%.
- Published
- 2021
- Full Text
- View/download PDF
12. Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February-May 2020
- Author
-
Miyahara, Reiko, Tsuchiya, Naho, Yasuda, Ikkoh, Ko, Yura K., Furuse, Yuki, Sando, Eiichiro, Nagata, Shohei, Imamura, Tadatsugu, Saito, Mayuko, Morimoto, Konosuke, Imamura, Takeaki, Shobugawa, Yugo, Nishiura, Hiroshi, Suzuki, Motoi, and Oshitani, Hitoshi
- Subjects
Family -- Health aspects ,Cluster analysis ,Health - Abstract
As of May 31, 2020, Japan had reported >16,800 confirmed coronavirus disease (COVID-19) cases and 890 related deaths. The cluster-based approach is one of the pillars of control measures in [...]
- Published
- 2021
- Full Text
- View/download PDF
13. Clusters of Coronavirus Disease in Communities, Japan, January–April 2020
- Author
-
Yuki Furuse, Eiichiro Sando, Naho Tsuchiya, Reiko Miyahara, Ikkoh Yasuda, Yura K. Ko, Mayuko Saito, Konosuke Morimoto, Takeaki Imamura, Yugo Shobugawa, Shohei Nagata, Kazuaki Jindai, Tadatsugu Imamura, Tomimasa Sunagawa, Motoi Suzuki, Hiroshi Nishiura, and Hitoshi Oshitani
- Subjects
respiratory infections ,severe acute respiratory syndrome coronavirus 2 ,SARS-CoV-2 ,SARS ,COVID-19 ,2019 novel coronavirus disease ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
We analyzed 3,184 cases of coronavirus disease in Japan and identified 61 case-clusters in healthcare and other care facilities, restaurants and bars, workplaces, and music events. We also identified 22 probable primary case-patients for the clusters; most were 20–39 years of age and presymptomatic or asymptomatic at virus transmission.
- Published
- 2020
- Full Text
- View/download PDF
14. Clusters of Coronavirus Disease in Communities, Japan, January-April 2020
- Author
-
Furuse, Yuki, Sando, Eiichiro, Tsuchiya, Naho, Miyahara, Reiko, Yasuda, Ikkoh, Ko, Yura K., Saito, Mayuko, Morimoto, Konosuke, Imamura, Takeaki, Shobugawa, Yugo, Nagata, Shohei, Jindai, Kazuaki, Imamura, Tadatsugu, Sunagawa, Tomimasa, Suzuki, Motoi, Nishiura, Hiroshi, and Oshitani, Hitoshi
- Subjects
Coronaviruses -- Analysis ,Public health -- Analysis ,COVID-19 -- Analysis ,Health - Abstract
Coronavirus disease (COVID-19) typically causes febrile illness with respiratory symptoms (1,2), and many countries worldwide have been affected. Before characterizing COVID-19 as a pandemic in March 2020 (3), the World [...]
- Published
- 2020
- Full Text
- View/download PDF
15. Roles of Children and Adolescents in COVID-19 Transmission in the Community: A Retrospective Analysis of Nationwide Data in Japan
- Author
-
Tadatsugu Imamura, Mayuko Saito, Yura K. Ko, Takeaki Imamura, Kanako Otani, Hiroki Akaba, Kota Ninomiya, Yuki Furuse, Reiko Miyahara, Eiichiro Sando, Ikkoh Yasuda, Naho Tsuchiya, The National COVID-19 Cluster Response Taskforce, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
COVID-19 ,children ,adolescent ,secondary transmission ,household transmission ,Pediatrics ,RJ1-570 - Abstract
Background: Roles of children and adolescents in spreading coronavirus disease 2019 (COVID-19) in the community is not fully understood.Methods: We analyzed the data of 7,758 children and adolescents with COVID-19 and characteristics of secondary transmission generated by these cases using case information published by local governments. Ratio of pediatric and adolescent cases generating secondary transmission was calculated for various social settings.Results: The incidence of COVID-19 was 24.8 cases per 105 population aged between 0 and 9 years, and 59.2 among those aged between 10 and 19 years, which was lower than that among individuals of all age groups (79.6 per 105 population) between January 15 and October 31, 2020. The proportion of cases generating secondary cases was 8.3% among infants and young children in nursery schools and kindergartens, 16% among children and adolescents attending primary schools, 34% among those attending junior high schools, 43% among those attending high schools, 31% among those attending professional training colleges, and 24% in those attending universities. Households were the most common setting for secondary transmission.Conclusion: The risk of generating secondary cases might be limited among pediatric and adolescent cases with COVID-19, especially in settings outside households. Effectiveness of traditional mitigation measures (e.g., school closures) to suppress COVID-19 transmissions should be carefully evaluated.
- Published
- 2021
- Full Text
- View/download PDF
16. Impact of the Coming‐of‐Age Day and ceremony on the risk of SARS‐CoV‐2 transmission in Japan: A natural‐experimental study based on national surveillance data
- Author
-
Yura K. Ko, Ryo Kinoshita, Masato Yamauchi, Kanako Otani, Taro Kamigaki, Kazuki Kasuya, Daisuke Yoneoka, Yuzo Arima, Yusuke Kobayashi, Takeshi Arashiro, Miyako Otsuka, Reiko Shimbashi, and Motoi Suzuki
- Subjects
Adult ,Pulmonary and Respiratory Medicine ,Infectious Diseases ,Japan ,SARS-CoV-2 ,Epidemiology ,Incidence ,Public Health, Environmental and Occupational Health ,COVID-19 ,Humans ,Public Health - Abstract
Quantifying the impact on COVID-19 transmission from a single event has been difficult due to the virus transmission dynamics, such as lag from exposure to reported infection, non-linearity arising from the person-to-person transmission, and the modifying effects of non-pharmaceutical interventions over time. To address these issues, we aimed to estimate the COVID-19 transmission risk of social events focusing on the Japanese Coming-of-Age Day and Coming-of-Age ceremony in which "new adults" practice risky behavior on that particular day.Using national surveillance data in Japan in 2021 and 2022, we conducted difference-in-differences regression against COVID-19 incidences by setting "new adults" cases as the treatment group and the cases 1 year younger or older than these "new adults" as the control group. In addition, we employed a triple differences approach to estimate the risk of holding the Coming-Age ceremony by using a binary variable regarding the presence or absence of the ceremony in each municipality.We estimated the relative risks (RRs) of the Coming-of-Age Day as 1.27 (95% confidence interval [CI] 1.02-1.57) in 2021 and 3.22 (95% CI 2.68-3.86) in 2022. The RR of the Coming-of-Age ceremony was also large, estimated as 2.83 (1.81-4.43) in 2022.When planning large social events, it is important to be aware of the unique risks associated with these gatherings, along with effective public health messages to best communicate these risks.
- Published
- 2022
- Full Text
- View/download PDF
17. COVID-19 case-clusters and transmission chains in the communities in Japan
- Author
-
Yuki Furuse, Hitoshi Oshitani, Kazuaki Jindai, Motoi Suzuki, Yura K Ko, Ikkoh Yasuda, Yugo Shobugawa, Atsuna Tokumoto, Konosuke Morimoto, Naho Tsuchiya, Eiichiro Sando, Tadatsugu Imamura, Takeaki Imamura, Shohei Nagata, and Reiko Miyahara
- Subjects
Microbiology (medical) ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,COVID-19 ,Virology ,law.invention ,Infectious Diseases ,Geography ,Transmission (mechanics) ,Japan ,law ,Cluster Analysis ,Humans ,Letter to the Editor - Published
- 2022
- Full Text
- View/download PDF
18. Integration of publicly available case-based data for real-time coronavirus disease 2019 risk assessment, Japan
- Author
-
Kota Ninomiya, Mariko Kanamori, Naomi Ikeda, Kazuaki Jindai, Yura K Ko, Kanako Otani, Yuki Furuse, Hiroki Akaba, Reiko Miyahara, Mayuki Saito, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
Japan ,COVID-19 ,Humans ,Public Health ,General Medicine ,Pandemics ,Risk Assessment - Abstract
In response to the outbreak of coronavirus disease 2019 (COVID-19) in Japan, a national COVID-19 cluster taskforce (comprising governmental and nongovernmental experts) was established to support the country’s Ministry of Health, Labour and Welfare in conducting daily risk assessment. The assessment was carried out using established infectious disease surveillance systems; however, in the initial stages of the pandemic these were not sufficient for real-time risk assessment owing to limited accessibility, delay in data entry and inadequate case information. Also, local governments were publishing anonymized data on confirmed COVID-19 cases on their official websites as daily press releases. We developed a unique database for nationwide real-time risk assessment that included these case lists from local government websites and integrated all case data into a standardized format. The database was updated daily and checked systematically to ensure comprehensiveness and quality. Between 15 January 2020 and 15 June 2021, 776 459 cases were logged in the database, allowing for analysis of real-time risk from the pandemic. This semi-automated database was used in daily risk assessments, and to evaluate and update control measures to prevent community transmission of COVID-19 in Japan. The data were reported almost every week to the Japanese Government Advisory Panel on COVID-19 for public health responses.
- Published
- 2022
- Full Text
- View/download PDF
19. Impact of the Coming-of-Age Day and ceremony on the risk of SARS-CoV-2 transmission in Japan: A natural-experimental study based on national surveillance data
- Author
-
Ko, Yura K, Kinoshita, Ryo, Yamauchi, Masato, Otani, Kanako, Kamigaki, Taro, Kasuya, Kazuki, Yoneoka, Daisuke, Arima, Yuzo, Kobayashi, Yusuke, Arashiro, Takeshi, Otsuka, Miyako, Shimbashi, Reiko, and Suzuki, Motoi
- Abstract
BACKGROUND: Quantifying the impact on COVID-19 transmission from a single event has been difficult due to the virus transmission dynamics, such as lag from exposure to reported infection, non-linearity arising from the person-to-person transmission, and the modifying effects of non-pharmaceutical interventions over time. To address these issues, we aimed to estimate the COVID-19 transmission risk of social events focusing on the Japanese Coming-of-Age Day and Coming-of-Age ceremony in which "new adults" practice risky behavior on that particular day. METHODS: Using national surveillance data in Japan in 2021 and 2022, we conducted difference-in-differences regression against COVID-19 incidences by setting "new adults" cases as the treatment group and the cases 1 year younger or older than these "new adults" as the control group. In addition, we employed a triple differences approach to estimate the risk of holding the Coming-Age ceremony by using a binary variable regarding the presence or absence of the ceremony in each municipality. RESULTS: We estimated the relative risks (RRs) of the Coming-of-Age Day as 1.27 (95% confidence interval [CI] 1.02-1.57) in 2021 and 3.22 (95% CI 2.68-3.86) in 2022. The RR of the Coming-of-Age ceremony was also large, estimated as 2.83 (1.81-4.43) in 2022. CONCLUSIONS: When planning large social events, it is important to be aware of the unique risks associated with these gatherings, along with effective public health messages to best communicate these risks.
- Published
- 2022
20. Epidemiology of Coronavirus Disease 2019 in Japan: Descriptive Findings and Lessons Learned through Surveillance during the First Three Waves
- Author
-
Kanako Otani, Tomimasa Sunagawa, Kazuhiko Kanou, Takeshi Arashiro, Reiko Miyahara, Takuri Takahashi, Motoi Suzuki, Yuzo Arima, Yuuki Tsuchihashi, and Yura K Ko
- Subjects
High peak ,medicine.medical_specialty ,Original Research Article: COVID-19 ,bias ,Younger age ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,business.industry ,Incidence (epidemiology) ,Context (language use) ,Asymptomatic ,Epidemiology ,surveillance ,medicine ,medicine.symptom ,business ,descriptive epidemiology ,Third wave ,Demography - Abstract
Introduction Coronavirus disease 2019 (COVID-19) has caused unprecedented global morbidity and mortality. Japan has faced three epidemic "waves" of COVID-19 from early 2020 through early 2021. Here we narratively review the three waves in Japan, describe the key epidemiologic features of COVID-19, and discuss lessons learned. Methods We assessed publicly available surveillance data, routine surveillance reports, and other relevant sources-multiple indicators were monitored to improve interpretation of surveillance data. Weekly trends for each wave were described based on the number of case notifications; number of tests performed; proportion of those tests that were positive for the novel coronavirus; the prevalent number of COVID-19 hospitalizations (total hospitalizations and those categorized as severe); and number of COVID-19 deaths. For each indicator and wave, we recorded the first calendar week to show an increase over two consecutive previous weeks, along with the peak week. Results The spring wave was characterized by detection of cases imported from China, followed by notifications of sporadic cases without travel history, clusters, and mild/asymptomatic cases. The summer wave saw a large increase in notifications and a younger age distribution, but in the context of increased testing with lower test positivity. The winter wave brought considerable morbidity and mortality, surpassing the cumulative case counts and fatalities from the earlier waves, with high peak values. Overall, relative to the first wave, the burden of severe outcomes was lower in the second and higher in the third wave, but varied by prefecture. In all three waves, severe outcomes peaked after notification counts and test positivity peaked; severe outcomes were also consistently skewed toward the elderly. Conclusions Important lessons were learned from each wave and across waves-some aspects remained constant, while others changed over time. In order to rapidly detect an increase in incidence, continuous, timely, and sensitive surveillance-using multiple information sources with careful interpretations-will be key in COVID-19 control.
- Published
- 2021
- Full Text
- View/download PDF
21. Secondary attack rates of SARS-CoV-2 alpha and delta variants in Japan
- Author
-
Reiko Miyahara, Kosuke Tamura, Tomoko Kato, Kanako Otani, Yura K Ko, Yuzo Arima, Hideki Tani, Kazunori Oishi, and Motoi Suzuki
- Abstract
BackgroundsThis study analysed secondary attack rates (SARs), comparing alpha variants, delta variants and non-variants of concern (non-VOCs), using clinical and close-contact tracing data.MethodsWe analysed coronavirus disease 2019 (COVID-19) case data from a database and contact tracing data between July and October 2020 (Cohort 1) and April 2021 (Cohort 2) and between July and August 2021 (Cohort 3) in a city in Toyama prefecture, Japan. Real-time polymerase chain reaction (PCR) was used to detect the N501Y (alpha variant) and L452R (delta variant) mutations. We calculated the SARs considering close contact, index case and contact setting characteristics. Relative risks (RRs) of secondary attack were analysed using Poisson regression models.ResultsAmong 123 index cases and 530 close contacts in Cohort 1, 246 index cases and 988 close contacts in Cohort 2, and 304 index cases and 984 close contacts in Cohort 3, the SARs associated with alpha and delta variant index cases were 1.47 times and 1.89 times higher than those associated with non-VOC index cases. Delta variant index cases were associated with the highest SAR (29.2%) in the same household and a 2.40-fold (95% CI: 1.62-3.56) higher risk of transmission than non-VOC index cases. The age and symptoms of index cases were associated with the SAR.ConclusionsWe confirmed that VOC index cases were associated with increased transmissibility. Population longitudinal surveillance data linked with contact-tracing data provide valuable information for elucidation of the characteristics of newly emerging variants.
- Published
- 2022
- Full Text
- View/download PDF
22. Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan
- Author
-
10895535, 70432987, Kayano, Taishi, Sasanami, Misaki, Kobayashi, Tetsuro, Ko, Yura K., Otani, Kanako, Suzuki, Motoi, Nishiura, Hiroshi, 10895535, 70432987, Kayano, Taishi, Sasanami, Misaki, Kobayashi, Tetsuro, Ko, Yura K., Otani, Kanako, Suzuki, Motoi, and Nishiura, Hiroshi
- Abstract
Background: In Japan, vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initiated on 17 February 2021, mainly using messenger RNA vaccines and prioritizing health care professionals. Whereas nationwide vaccination alleviated the coronavirus disease 2019 (COVID-19)-related burden, the population impact has yet to be quantified in Japan. We aimed to estimate the numbers of COVID-19 cases and deaths prevented that were attributable to the reduced risk among vaccinated individuals via a statistical modeling framework. Methods: We analyzed confirmed cases registered in the Health Center Real-time Information-sharing System on COVID-19 (3 March–30 November 2021) and publicly reported COVID-19-related deaths (24 March–30 November 2021). The vaccination coverage over this time course, classified by age and sex, was extracted from vaccine registration systems. The total numbers of prevented cases and deaths were calculated by multiplying the daily risk differences between unvaccinated and vaccinated individuals by the population size of vaccinated individuals. Findings: For both cases and deaths, the averted numbers were estimated to be the highest among individuals aged 65 years and older. In total, we estimated that 564, 596 (95% confidence interval: 477, 020–657, 525) COVID-19 cases and 18, 622 (95% confidence interval: 6522–33, 762) deaths associated with SARS-CoV-2 infection were prevented owing to vaccination during the analysis period (i.e., fifth epidemic wave, caused mainly by the Delta variant). Female individuals were more likely to be protected from infection following vaccination than male individuals whereas more deaths were prevented in male than in female individuals. Interpretation: The vaccination program in Japan led to substantial reductions in the numbers of COVID-19 cases and deaths (33% and 67%, respectively). The preventive effect will be further amplified during future pandemic waves caused by variants with shared a
- Published
- 2022
23. Impact of pathogenic mutations of the GLUT1 glucose transporter on solute carrier dynamics using ComDYN enhanced sampling
- Author
-
Mouhib, H. (Halima), Higuchi, A. (Akiko), Abeln, S. (Sanne), Yura, K. (Kei), Feenstra, K.A. (Anton), Mouhib, H. (Halima), Higuchi, A. (Akiko), Abeln, S. (Sanne), Yura, K. (Kei), and Feenstra, K.A. (Anton)
- Abstract
Background: The solute carrier (SLC) family of membrane proteins is a large class of transporters for many small molecules that are vital for cellular function. Several pathogenic mutations are reported in the glucose transporter subfamily SLC2, causing Glut1-deficiency syndrome (GLUT1DS1, GLUT1DS2), epilepsy (EIG2) and cryohydrocytosis with neurological defects (Dystonia-9). Understanding the link between these mutations and transporter dynamics is crucial to elucidate their role in the dysfunction of the underlying transport mechanism, which we investigate using molecular dynamics simulations. Methods: We studied pathogenic and non-pathogenic mutations, using a newly developed coarse-grained simulation approach ‘ComDYN’, which captures the ‘COMmon constraints DYNamics’ between both states of the solute carrier protein. To guarantee the sampling of large conformational changes, we only include common constraints of the elastic network introduced upon coarse-graining, which showed similar reference distances between both conformational states (≤1 Å difference). Results: ComDYN is computationally efficient and sufficiently sensitive to capture effects of different mutations. Our results clearly indicate that the pathogenic mutation in GLUT1, G91D, situated at the highly conserved RXGRR motif between helices 2 and 3, has a strong impact on transporter function, as it blocks the protein from sampling both conformational states. In comparison, predictions from SIFT and PolyPhen only provided an impression of the impact upon mutation in the highly conserved RXGRR motifs, but yielded no clear differentiation between pathogenic and non-pathogenic mutations. Conclusions: Using our approach, we can explain the pathogenicity of the mutation G91D and some of the effects of other known pathogenic mutations, when we observe the configurations of the transmembrane helices, suggesting that their relative position is crucial for the correct functioning of the GLUT1 protein. To full
- Published
- 2022
- Full Text
- View/download PDF
24. Secondary attack rates of SARS-CoV-2 alpha and delta variants in Japan
- Author
-
Miyahara, Reiko, primary, Tamura, Kosuke, additional, Kato, Tomoko, additional, Otani, Kanako, additional, Ko, Yura K, additional, Arima, Yuzo, additional, Tani, Hideki, additional, Oishi, Kazunori, additional, and Suzuki, Motoi, additional
- Published
- 2022
- Full Text
- View/download PDF
25. Evaluating the Age-Specific Effectiveness of COVID-19 Vaccines Against Death and the Impact of Healthcare Burden on Age-Specific Case Fatality Risk in Tokyo, Japan
- Author
-
Yura K. Ko, Hiroaki Murayama, Lisa Yamasaki, Ryo Kinoshita, Motoi Suzuki, and Hiroshi Nishiura
- Published
- 2022
- Full Text
- View/download PDF
26. COVID-19 case-clusters and transmission chains in the communities in Japan
- Author
-
Furuse, Yuki, primary, Tsuchiya, Naho, additional, Miyahara, Reiko, additional, Yasuda, Ikkoh, additional, Sando, Eiichiro, additional, Ko, Yura K, additional, Imamura, Takeaki, additional, Morimoto, Konosuke, additional, Imamura, Tadatsugu, additional, Shobugawa, Yugo, additional, Nagata, Shohei, additional, Tokumoto, Atsuna, additional, Jindai, Kazuaki, additional, Suzuki, Motoi, additional, and Oshitani, Hitoshi, additional
- Published
- 2022
- Full Text
- View/download PDF
27. Evaluating the Age-Specific Effectiveness of COVID-19 Vaccines Against Death and the Impact of Healthcare Burden on Age-Specific Case Fatality Risk in Tokyo, Japan
- Author
-
Ko, Yura K., primary, Murayama, Hiroaki, additional, Yamasaki, Lisa, additional, Kinoshita, Ryo, additional, Suzuki, Motoi, additional, and Nishiura, Hiroshi, additional
- Published
- 2022
- Full Text
- View/download PDF
28. Integration of publicly available case-based data for real-time coronavirus disease 2019 risk assessment, Japan
- Author
-
Ninomiya, Kota, primary, Kanamori, Mariko, additional, Ikeda, Naomi, additional, Jindai, Kazuaki, additional, Ko, Yura K, additional, Otani, Kanako, additional, Furuse, Yuki, additional, Akaba, Hiroki, additional, Miyahara, Reiko, additional, Saito, Mayuki, additional, Suzuki, Motoi, additional, and Oshitani, Hitoshi, additional
- Published
- 2022
- Full Text
- View/download PDF
29. Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion
- Author
-
Yura K Ko, Yuki Furuse, Kota Ninomiya, Kanako Otani, Hiroki Akaba, Reiko Miyahara, Tadatsugu Imamura, Takeaki Imamura, Alex R Cook, Mayuko Saito, Motoi Suzuki, and Hitoshi Oshitani
- Subjects
Microbiology (medical) ,super spreading events ,SARS-CoV-2 ,overdispersion ,Super-spreading events ,COVID-19 ,General Medicine ,Infectious and parasitic diseases ,RC109-216 ,Article ,secondary transmission ,Infectious Diseases ,Japan ,Humans ,Demography ,dispersion parameter - Abstract
Objsectives: Super-spreading events caused by overdispersed secondary transmission is crucial in the transmission of coronavirus disease 2019 (COVID-19). However, the exact level of overdispersion, demographics, and other factors associated with secondary transmission remain elusive. In this study, we aimed to elucidate the frequency and patterns of secondary transmission of SARS-CoV-2 in Japan. Methods: We analyzed 16,471 cases between January and August 2020. We generated the number of secondary cases distribution and estimated the dispersion parameter (k) by fitting the negative binomial distribution in each phase. The frequencies of the secondary transmission were compared by demographic and clinical characteristics, calculating the odds ratio by logistic regression models. Results: We observed that 76.7% of the primary cases did not generate secondary cases with an estimated dispersion parameter k of 0.23. The demographic patterns of primary-secondary cases differed between phases, with 20–69 years being the predominant age group. There were higher proportions of secondary cases among elderly, symptomatic cases, and those with two days or more between onset and confirmation. Conclusions: The study demonstrated the estimation of the frequency of secondary transmission of SARS-CoV-2 and the characteristics of people who generated the secondary transmission.
- Published
- 2021
30. Edible wild field cricket (Brachytrupes portentosus) trading in Bangladesh
- Author
-
Hasan, M.M., primary, Rahman, M.M., additional, Kataoka, K., additional, Yura, K., additional, Faruque, M.O., additional, Shadhen, F.R., additional, and Mondal, M.F., additional
- Published
- 2021
- Full Text
- View/download PDF
31. Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics
- Author
-
Kota Ninomiya, Motoi Suzuki, Hitoshi Oshitani, Yuki Furuse, and Yura K Ko
- Subjects
Test strategy ,medicine.medical_specialty ,Isolation (health care) ,Health, Toxicology and Mutagenesis ,Basic Reproduction Number ,Disease cluster ,epidemics ,effective reproduction number ,03 medical and health sciences ,0302 clinical medicine ,Japan ,Pandemic ,Epidemiology ,medicine ,Humans ,030212 general & internal medicine ,Pandemics ,laboratory diagnosis ,030304 developmental biology ,0303 health sciences ,business.industry ,SARS-CoV-2 ,Public health ,Brief Report ,pandemic ,Public Health, Environmental and Occupational Health ,COVID-19 ,Test (assessment) ,outbreaks ,surveillance ,Medicine ,business ,Basic reproduction number ,Demography - Abstract
Detection and isolation of infected people are believed to play an important role in the control of the COVID-19 pandemic. Some countries conduct large-scale screenings for testing, whereas others test mainly people with high prior probability of infection such as showing severe symptoms and/or having an epidemiological link with a known or suspected case or cluster of cases. However, what a good testing strategy is and whether the difference in testing strategy shows a meaningful, measurable impact on the COVID-19 epidemic remain unknown. Here, we showed that patterns of association between effective reproduction number (Rt) and test positivity rate can illuminate differences in testing situation among different areas, using global and local data from Japan. This association can also evaluate the adequacy of current testing systems and what information is captured in COVID-19 surveillance. The differences in testing systems alone cannot predict the results of epidemic containment efforts. Furthermore, monitoring test positivity rates and severe case proportions among the nonelderly can predict imminent case count increases. Monitoring test positivity rates in conjunction with the concurrent Rt could be useful to assess and strengthen public health management and testing systems and deepen understanding of COVID-19 epidemic dynamics.
- Published
- 2021
32. Epidemiology of COVID-19 Outbreak in Japan, from January–March 2020
- Author
-
Yuki, Furuse, Yura K, Ko, Mayuko, Saito, Yugo, Shobugawa, Kazuaki, Jindai, Tomoya, Saito, Hiroshi, Nishiura, Tomimasa, Sunagawa, Motoi, Suzuki, Hitoshi, Oshitani, National Task Force for COVID-19 Outbreak in Japan, Yuki, Furuse, Yura K, Ko, Mayuko, Saito, Yugo, Shobugawa, Kazuaki, Jindai, Tomoya, Saito, Hiroshi, Nishiura, Tomimasa, Sunagawa, Motoi, Suzuki, Hitoshi, Oshitani, and National Task Force for COVID-19 Outbreak in Japan
- Abstract
source:Epub 2020 Apr 30, source:https://pubmed.ncbi.nlm.nih.gov/32350228, source:https://cir.nii.ac.jp/crid/1390004222621475200
- Published
- 2021
33. Serum thrombopoietin level and thrombocytopenia during the neonatal period in infants with Down's syndrome
- Author
-
Matsubara, K, Nigami, H, Yura, K, Inoue, T, Isome, K, and Fukaya, T
- Published
- 2010
- Full Text
- View/download PDF
34. Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment.
- Author
-
Yusuke Kobayashi, Takeshi Arashiro, Miyako Otsuka, Yuuki Tsuchihashi, Takuri Takahashi, Yuzo Arima, Yura K. Ko, Kanako Otani, Masato Yamauchi, Taro Kamigaki, Tomoko Morita-Ishihara, Hiromizu Takahashi, Sana Uchikoba, Michitsugu Shimatani, Nozomi Takeshita, Motoi Suzuki, and Makoto Ohnishi
- Subjects
SARS-CoV-2 ,SARS-CoV-2 Delta variant - Abstract
Objective: Monitoring the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is important due to concerns regarding infectivity, transmissibility, immune evasion and disease severity. We evaluated the temporal and regional replacement of previous SARS-CoV-2 variants by the emergent strains, Alpha and Delta. Methods: We obtained the results of polymerase chain reaction screening tests for variants conducted in multiple commercial laboratories. Assuming that all previous strains would be replaced by one variant, the new variant detection rate was estimated by fitting a logistic growth model. We estimated the transmission advantage of each new variant over the preexisting virus strains. Results: The variant with the N501Y mutation was first identified in the Kinki region in early February 2021, and by early May, it had replaced more than 90% of the previous strains. The variant with the L452R mutation was first detected in the Kanto-Koshin region in mid-May, and by early August, it comprised more than 90% of the circulating strains. Compared with pre-existing strains, the variant with the N501Y mutation showed transmission advantages of 48.2% and 40.3% in the Kanto-Koshin and Kinki regions, respectively, while the variant with the L452R mutation showed transmission advantages of 60.1% and 71.9%, respectively. Discussion: In Japan, Alpha and Delta variants displayed regional differences in the replacement timing and their relative transmission advantages. Our method is efficient in monitoring and estimating changes in the proportion of variant strains in a timely manner in each region. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics
- Author
-
Furuse, Yuki, primary, Ko, Yura K., additional, Ninomiya, Kota, additional, Suzuki, Motoi, additional, and Oshitani, Hitoshi, additional
- Published
- 2021
- Full Text
- View/download PDF
36. Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February−May 2020
- Author
-
Miyahara, Reiko, primary, Tsuchiya, Naho, additional, Yasuda, Ikkoh, additional, Ko, Yura K., additional, Furuse, Yuki, additional, Sando, Eiichiro, additional, Nagata, Shohei, additional, Imamura, Tadatsugu, additional, Saito, Mayuko, additional, Morimoto, Konosuke, additional, Imamura, Takeaki, additional, Shobugawa, Yugo, additional, Nishiura, Hiroshi, additional, Suzuki, Motoi, additional, and Oshitani, Hitoshi, additional
- Published
- 2021
- Full Text
- View/download PDF
37. Epidemiology of COVID-19 Outbreak in Japan, from January-March 2020
- Author
-
Yuki, Furuse, Yura K, Ko, Mayuko, Saito, Yugo, Shobugawa, Kazuaki, Jindai, Tomoya, Saito, Hiroshi, Nishiura, Tomimasa, Sunagawa, Motoi, Suzuki, Hitoshi, Oshitani, and National Task Force for COVID-19 Outbreak in Japan
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Betacoronavirus ,Japan ,Risk Factors ,Pandemic ,Epidemiology ,Medicine ,Humans ,Pandemics ,biology ,business.industry ,SARS-CoV-2 ,Incidence (epidemiology) ,Incidence ,Outbreak ,COVID-19 ,General Medicine ,biology.organism_classification ,Virology ,Infectious Diseases ,Contact Tracing ,business ,Coronavirus Infections ,Contact tracing - Published
- 2020
38. Repetitive use of a phosphate-binding module in DNA polymerase β, Oct-1 POU domain and phage repressors
- Author
-
Yura, K., Shionyu, M., Kawatani, K., and Gō, M.
- Published
- 1999
- Full Text
- View/download PDF
39. Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February-May 2020.
- Author
-
Reiko Miyahara, Naho Tsuchiya, Ikkoh Yasuda, Ko, Yura K., Yuki Furuse, Eiichiro Sando, Shohei Nagata, Tadatsugu Imamura, Mayuko Saito, Konosuke Morimoto, Takeaki Imamura, Yugo Shobugawa, Hiroshi Nishiura, Motoi Suzuki, Hitoshi Oshitani, Miyahara, Reiko, Tsuchiya, Naho, Yasuda, Ikkoh, Furuse, Yuki, and Sando, Eiichiro
- Subjects
COVID-19 ,RESPIRATORY infections - Abstract
The overall coronavirus disease secondary attack rate (SAR) in family members was 19.0% in 10 prefectures of Japan during February 22-May 31, 2020. The SAR was lower for primary cases diagnosed early, within 2 days after symptom onset. The SAR of asymptomatic primary cases was 11.8%. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. The difference in endocochlear and endolymphatic sac d.c. potentials in response to furosemide and canrenoate as diuretics
- Author
-
Mori, N., Uozumi, N., Yura, K., and Sakai, S.
- Published
- 1990
- Full Text
- View/download PDF
41. The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts
- Author
-
Yamasaki, C., Murakami, K., Fujii, Y., Sato, Y., Harada, E., Takeda, J., Taniya, T., Sakate, R., Kikugawa, S., Shimada, M., Tanino, M., Koyanagi, K.O., Barrero, R.A., Gough, C., Chun, H., Habara, T., Hanaoka, H., Hayakawa, Y., Hilton, P.B., Kaneko, Y., Kanno, M., Kawahara, Y., Kawamura, T., Matsuya, A., Nagata, N., Nishikata, K., Noda, A.O., Nurimoto, S., Saichi, N., Sakai, H., Sanbonmatsu, R., Shiba, R., Suzuki, M., Takabayashi, K., Takahashi, A., Tamura, T., Tanaka, M., Tanaka, S., Todokoro, F., Yamaguchi, K., Yamamoto, N., Okido, T., Mashima, J., Hashizume, A., Jin, L., Lee, K., Lin, Y., Nozaki, A., Sakai, K., Tada, M., Miyazaki, S., Makino, T., Ohyanagi, H., Osato, N., Tanaka, N., Suzuki, Y., Ikeo, K., Saitou, N., Sugawara, H., O'Donovan, C., Kulikova, T., Whitfield, E., Halligan, B., Shimoyama, M., Twigger, S., Yura, K., Kimura, K., Yasuda, T., Nishikawa, T., Akiyama, Y., Motono, C., Mukai, Y., Nagasaki, H., Suwa, M., Horton, P., Kikuno, R., Ohara, O., Lancet, D., Eveno, E., Graudens, E., Imbeaud, S., Debily, M., Hayashizaki, Y., Amid, C., Han, M., Osanger, A., Endo, T., Thomas, M.A., Hirakawa, M., Makalowski, W., Nakao, M., Kim, N., Yoo, H., de Souza, S.J., Bonaldo, M.D.F., Niimura, Y., Kuryshev, V., Schupp, I., Wiemann, S., Bellgard, M., Shionyu, M., Jia, L., Thierry-Mieg, D., Thierry-Mieg, J., Wagner, L., Zhang, Q., Go, M., Minoshima, S., Ohtsubo, M., Hanada, K., Tonellato, P., Isogai, T., Zhang, J., Lenhard, B., Kim, S., Chen, Z., Hinz, U., Estreicher, A., Nakai, K., Makalowska, I., Hide, W., Tiffin, N., Wilming, L., Chakraborty, R., Soares, M.B., Chiusano, M.L., Auffray, C., Yamaguchi-Kabata, Y., Itoh, T., Hishiki, T., Fukuchi, S., Nishikawa, K., Sugano, S., Nomura, N., Tateno, Y., Imanishi, T., Gojobori, T., Genexpress, Centre National de la Recherche Scientifique (CNRS), Yamasaki, C., Murakami, K., Fujii, Y., Sato, Y., Harada, E., Takeda, J., Taniya, T., Sakate, R., Kikugawa, S., Shimada, M., Tanino, M., Koyanagi, K. O., Barrero, R. A., Gough, C., Chun, H. W., Habara, T., Hanaoka, H., Hayakawa, Y., Hilton, P. B., Kaneko, Y., Kanno, M., Kawahara, Y., Kawamura, T., Matsuya, A., Nagata, N., Nishikata, K., Noda, A. O., Nurimoto, S., Saichi, N., Sakai, H., Sanbonmatsu, R., Shiba, R., Suzuki, M., Takabayashi, K., Takahashi, A., Tamura, T., Tanaka, M., Tanaka, S., Todokoro, F., Yamaguchi, K., Yamamoto, N., Okido, T., Mashima, J., Hashizume, A., Jin, L., Lee, K. B., Lin, Y. C., Nozaki, A., Sakai, K., Tada, M., Miyazaki, S., Makino, T., Ohyanagi, H., Osato, N., Tanaka, N., Suzuki, Y., Ikeo, K., Saitou, N., Sugawara, H., Odonovan, C., Kulikova, T., Whitfield, E., Halligan, B., Shimoyama, M., Twigger, S., Yura, K., Kimura, K., Yasuda, T., Nishikawa, T., Akiyama, Y., Motono, C., Mukai, Y., Nagasaki, H., Suwa, M., Horton, P., Kikuno, R., Ohara, O., Lancet, D., Eveno, E., Graudens, E., Imbeaud, S., Debily, M. A., Hayashizaki, Y., Amid, C., Han, M., Osanger, A., Endo, T., Thomas, M. A., Hirakawa, M., Makalowski, W., Nakao, M., Kim, N. S., Yoo, H. S., De Souza, S. J., Bonaldo Mde, F., Niimura, Y., Kuryshev, V., Schupp, I., Wiemann, S., Bellgard, M., Shionyu, M., Jia, L., Thierry Mieg, D., Thierry Mieg, J., Wagner, L., Zhang, Q., Go, M., Minoshima, S., Ohtsubo, M., Hanada, K., Tonellato, P., Isogai, T., Zhang, J., Lenhard, B., Kim, S., Chen, Z., Hinz, U., Estreicher, A., Nakai, K., Makalowska, I., Hide, W., Tiffin, N., Wilming, L., Chakraborty, R., Soares, M. B., Chiusano, MARIA LUISA, Auffray, C., Yamaguchi Kabata, Y., Itoh, T., Hishiki, T., Fukuchi, S., Nishikawa, K., Sugano, S., Nomura, N., Tateno, Y., Imanishi, T., and Gojobori, T.
- Subjects
DNA, Complementary ,[SDV]Life Sciences [q-bio] ,Pseudogene ,Locus (genetics) ,Biology ,computer.software_genre ,User-Computer Interface ,03 medical and health sciences ,Annotation ,0302 clinical medicine ,Databases, Genetic ,Genetics ,Animals ,Humans ,Gene family ,RNA, Messenger ,Gene ,database ,030304 developmental biology ,Internet ,0303 health sciences ,Human genome ,Database ,Alternative splicing ,Chromosome Mapping ,Proteins ,Articles ,Gene expression profiling ,Genes ,transcriptome ,computer ,030217 neurology & neurosurgery - Abstract
International audience; Here we report the new features and improvements in our latest release of the H-Invitational Database (H-InvDB; http://www.h-invitational.jp/), a comprehensive annotation resource for human genes and transcripts. H-InvDB, originally developed as an integrated database of the human transcriptome based on extensive annotation of large sets of full-length cDNA (FLcDNA) clones, now provides annotation for 120 558 human mRNAs extracted from the International Nucleotide Sequence Databases (INSD), in addition to 54 978 human FLcDNAs, in the latest release H-InvDB_4.6. We mapped those human transcripts onto the human genome sequences (NCBI build 36.1) and determined 34 699 human gene clusters, which could define 34 057 (98.1%) protein-coding and 642 (1.9%) non-protein-coding loci; 858 (2.5%) transcribed loci overlapped with predicted pseudogenes. For all these transcripts and genes, we provide comprehensive annotation including gene structures, gene functions, alternative splicing variants, functional non-protein-coding RNAs, functional domains, predicted sub cellular localizations, metabolic pathways, predictions of protein 3D structure, mapping of SNPs and microsatellite repeat motifs, co-localization with orphan diseases, gene expression profiles, orthologous genes, protein-protein interactions (PPI) and annotation for gene families. The current H-InvDB annotation resources consist of two main views: Transcript view and Locus view and eight sub-databases: the DiseaseInfo Viewer, H-ANGEL, the Clustering Viewer, G-integra, the TOPO Viewer, Evola, the PPI view and the Gene family/group.
- Published
- 2007
- Full Text
- View/download PDF
42. Optimization analysis for recycle-oriented manufacturing systems.
- Author
-
Hoshino, T., Yura, K., and Hitomi, K.
- Subjects
WASTE recycling ,MANUFACTURING processes - Abstract
Recycling has been recently recognized as one of effective tools for solving environmental problems. In this respect present and future manufacturing systems should take the recycling of materials used into consideration. This paper points out the issues contained in such a recycle-oriented manufacturing system, then the basic parts-flow in the product's life cycle is clarified by taking account of re-use and re-production of the parts contained in the product. A model is constructed to maximize two measures of performance—total profit and recycling rate. This is solved by goal programming. Finally, a numerical example is used to demonstrate the effectiveness of the model proposed. [ABSTRACT FROM AUTHOR]
- Published
- 1995
- Full Text
- View/download PDF
43. 1120 Spontaneous recovery of cavernous function after radical prostatectomy
- Author
-
Miyake, T., primary, Kawanishi, Y., additional, Izumi, K., additional, Muguruma, H., additional, Sasaki, Y., additional, Yura, K., additional, Kishimoto, T., additional, Yamanaka, M., additional, Fukawa, T., additional, and Hiroomi, K., additional
- Published
- 2016
- Full Text
- View/download PDF
44. 51 Virtual cavernoscopic classification of arteries within the corpus cavernosum
- Author
-
Izumi, K., primary, Kawanishi, Y., additional, Miyake, T., additional, Yura, K., additional, Fujisawa, H., additional, Kishimoto, T., additional, Yamanaka, M., additional, Fukawa, T., additional, and Kanayama, H., additional
- Published
- 2015
- Full Text
- View/download PDF
45. Integrative Annotation of 21,037 Human Genes\ud Validated by Full-Length cDNA Clones
- Author
-
Imanishi, T., Itoh, T., Suzuki, Y., O'Donovan, C., Fukuchi, S., Koyanagi, K.O., Barrero, R.A., Tamura, T., Yamaguchi-Kabata, Y., Tanino, M., Yura, K., Miyazaki, S., Ikeo, K., Homma, K., Kasprzyk, A., Nishikawa, T., Hirakawa, M., Thierry-Mieg, J., Thierry-Mieg, D., Ashurst, J., Jia, L., Nakao, M., Thomas, M.A., Mulder, N., Karavidopoulou, Y., Jin, L., Kim, S., Yasuda, T., Lenhard, B., Eveno, E., Yamasaki, C., Takeda, J., Gough, C., Hilton, P., Fujii, Y., Sakai, H., Tanaka, S., Amid, C., Bellgard, M., De Fatima Bonaldo, M., Bono, H., Bromberg, S.K., Brookes, A.J., Bruford, E., Carninci, P., Chelala, C., Couillault, C., de Souza, S.J., Debily, M., Devignes, M., Dubchak, I., Endo, T., Estreicher, A., Eyras, E., Fukami-Kobayashi, K., Gopinath, G.R., Graudens, E., Hahn, Y., Han, M., Han, Z., Hanada, K., Hanaoka, H., Harada, E., Hinz, U., Hishiki, T., Hopkinson, I., Imbeaud, S., Inoko, H., Kanapin, A., Kaneko, Y., Kasukawa, T., Kersey, P., Kikuno, R., Kimura, K., Korn, B., Kuryshev, V., Makalowska, I., Makino, T., Mano, S., Mariage-Samson, R., Mashima, J., Matsuda, H., Mewes, H., Minoshima, S., Nagai, K., Nagasaki, H., Nagata, N., Nigam, R., Ogasawara, O., Ohara, O., Ohtsubo, M., Okido, T., Oota, S., Ota, M., Ota, T., Otsuki, T., Piatier-Tonneau, D., Poustka, A., Ren, S., Saitou, N., Sakai, K., Sakamoto, S., Sakate, R., Schupp, I., Servant, F., Sherry, S., Shiba, R., Shimizu, N., Shimoyama, M., Simpson, A.J., Soares, B., Steward, C., Suwa, M., Suzuki, M., Takahashi, A., Tamiya, G., Tanaka, H., Taylor, T., Terwilliger, J.D., Unneberg, P., Veeramachaneni, V., Watanabe, S., Wilming, L., Yasuda, N., Yoo, H-S., Stodolsky, M., Makalowski, W., Go, M., Nakai, K., Takagi, T., Kanehisa, M., Sakaki, Y., Quackenbush, J., Okazaki, Y., Hayashizaki, Y., Hide, W., Chakraborty, R., Nishikawa, K., Sugawara, H., Tateno, Y., Chen, Z., Oishi, M., Tonellato, P., Apweiler, R., Okubo, K., Wagner, L., Wiemann, S., Strausberg, R.L., Isogai, T., Auffray, C., Nomura, N., Gojobori, T., and Sugano, S.
- Abstract
The human genome sequence defines our inherent biological potential; the realization of the biology encoded therein\ud requires knowledge of the function of each gene. Currently, our knowledge in this area is still limited. Several lines of\ud investigation have been used to elucidate the structure and function of the genes in the human genome. Even so, gene\ud prediction remains a difficult task, as the varieties of transcripts of a gene may vary to a great extent. We thus\ud performed an exhaustive integrative characterization of 41,118 full-length cDNAs that capture the gene transcripts as\ud complete functional cassettes, providing an unequivocal report of structural and functional diversity at the gene level.\ud Our international collaboration has validated 21,037 human gene candidates by analysis of high-quality full-length\ud cDNA clones through curation using unified criteria. This led to the identification of 5,155 new gene candidates. It also\ud manifested the most reliable way to control the quality of the cDNA clones. We have developed a human gene\ud database, called the H-Invitational Database (H-InvDB; http://www.h-invitational.jp/). It provides the following:\ud integrative annotation of human genes, description of gene structures, details of novel alternative splicing isoforms,\ud non-protein-coding RNAs, functional domains, subcellular localizations, metabolic pathways, predictions of protein\ud three-dimensional structure, mapping of known single nucleotide polymorphisms (SNPs), identification of polymorphic\ud microsatellite repeats within human genes, and comparative results with mouse full-length cDNAs. The H-InvDB\ud analysis has shown that up to 4% of the human genome sequence (National Center for Biotechnology Information\ud build 34 assembly) may contain misassembled or missing regions. We found that 6.5% of the human gene candidates\ud (1,377 loci) did not have a good protein-coding open reading frame, of which 296 loci are strong candidates for nonprotein-coding\ud RNA genes. In addition, among 72,027 uniquely mapped SNPs and insertions/deletions localized within\ud human genes, 13,215 nonsynonymous SNPs, 315 nonsense SNPs, and 452 indels occurred in coding regions. Together\ud with 25 polymorphic microsatellite repeats present in coding regions, they may alter protein structure, causing\ud phenotypic effects or resulting in disease. The H-InvDB platform represents a substantial contribution to resources\ud needed for the exploration of human biology and pathology
- Published
- 2004
46. The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts.
- Author
-
Yamasaki, C., Murakami, K., Fujii, Y., Sato, Y., Harada, E., Takeda, J-I, Taniya, T., Sakate, R., Kikugawa, S., Shimada, M., Tanino, M., Koyanagi, K.O., Barrero, R.A., Gough, C., Chun, H-W, Habara, T., Hanaoka, H., Hayakawa, Y., Hilton, P.B., Kaneko, Y., Kanno, M., Kawahara, Y., Kawamura, T., Matsuya, A., Nagata, N., Nishikata, K., Noda, A.O., Nurimoto, S., Saichi, N., Sakai, H., Sanbonmatsu, R., Shiba, R., Suzuki, M., Takabayashi, K., Takahashi, A., Tamura, T., Tanaka, M., Tanaka, S., Todokoro, F., Yamaguchi, K., Yamamoto, N., Okido, T., Mashima, J., Hashizume, A., Jin, L., Lee, K-B, Lin, Y-C, Nozaki, A., Sakai, K., Tada, M., Miyazaki, S., Makino, T., Ohyanagi, H., Osato, N., Tanaka, N., Suzuki, Y., Ikeo, K., Saitou, N., Sugawara, H., O'Donovan, C., Kulikova, T., Whitfield, E., Halligan, B., Shimoyama, M., Twigger, S., Yura, K., Kimura, K., Yasuda, T., Nishikawa, T., Akiyama, Y., Motono, C., Mukai, Y., Nagasaki, H., Suwa, M., Horton, P., Kikuno, R., Ohara, O., Lancet, D., Eveno, E., Graudens, E., Imbeaud, S., Debily, M.A., Hayashizaki, Y., Amid, C., Han, M., Osanger, A., Endo, T., Thomas, M.A., Hirakawa, M., Makalowski, W., Nakao, M., Kim, N-S, Yoo, H-S, De Souza, S.J., Bonaldo, M., Niimura, Y., Kuryshev, V., Schupp, I., Wiemann, S., Bellgard, M., Shionyu, M., Jia, L., Thierry-Mieg, D., Thierry-Mieg, J., Wagner, L., Zhang, Q., Go, M., Minoshima, S., Ohtsubo, M., Hanada, K., Tonellato, P., Isogai, T., Zhang, J., Lenhard, B., Kim, S., Chen, Z., Hinz, U., Estreicher, A., Nakai, K., Makalowska, I., Hide, W., Tiffin, N., Wilming, L., Chakraborty, R., Soares, M.B., Chiusano, M.L., Auffray, C., Yamaguchi-Kabata, Y., Itoh, T., Hishiki, T., Fukuchi, S., Nishikawa, K., Sugano, S., Nomura, N., Tateno, Y., Imanishi, T., Gojobori, T., Yamasaki, C., Murakami, K., Fujii, Y., Sato, Y., Harada, E., Takeda, J-I, Taniya, T., Sakate, R., Kikugawa, S., Shimada, M., Tanino, M., Koyanagi, K.O., Barrero, R.A., Gough, C., Chun, H-W, Habara, T., Hanaoka, H., Hayakawa, Y., Hilton, P.B., Kaneko, Y., Kanno, M., Kawahara, Y., Kawamura, T., Matsuya, A., Nagata, N., Nishikata, K., Noda, A.O., Nurimoto, S., Saichi, N., Sakai, H., Sanbonmatsu, R., Shiba, R., Suzuki, M., Takabayashi, K., Takahashi, A., Tamura, T., Tanaka, M., Tanaka, S., Todokoro, F., Yamaguchi, K., Yamamoto, N., Okido, T., Mashima, J., Hashizume, A., Jin, L., Lee, K-B, Lin, Y-C, Nozaki, A., Sakai, K., Tada, M., Miyazaki, S., Makino, T., Ohyanagi, H., Osato, N., Tanaka, N., Suzuki, Y., Ikeo, K., Saitou, N., Sugawara, H., O'Donovan, C., Kulikova, T., Whitfield, E., Halligan, B., Shimoyama, M., Twigger, S., Yura, K., Kimura, K., Yasuda, T., Nishikawa, T., Akiyama, Y., Motono, C., Mukai, Y., Nagasaki, H., Suwa, M., Horton, P., Kikuno, R., Ohara, O., Lancet, D., Eveno, E., Graudens, E., Imbeaud, S., Debily, M.A., Hayashizaki, Y., Amid, C., Han, M., Osanger, A., Endo, T., Thomas, M.A., Hirakawa, M., Makalowski, W., Nakao, M., Kim, N-S, Yoo, H-S, De Souza, S.J., Bonaldo, M., Niimura, Y., Kuryshev, V., Schupp, I., Wiemann, S., Bellgard, M., Shionyu, M., Jia, L., Thierry-Mieg, D., Thierry-Mieg, J., Wagner, L., Zhang, Q., Go, M., Minoshima, S., Ohtsubo, M., Hanada, K., Tonellato, P., Isogai, T., Zhang, J., Lenhard, B., Kim, S., Chen, Z., Hinz, U., Estreicher, A., Nakai, K., Makalowska, I., Hide, W., Tiffin, N., Wilming, L., Chakraborty, R., Soares, M.B., Chiusano, M.L., Auffray, C., Yamaguchi-Kabata, Y., Itoh, T., Hishiki, T., Fukuchi, S., Nishikawa, K., Sugano, S., Nomura, N., Tateno, Y., Imanishi, T., and Gojobori, T.
- Abstract
Here we report the new features and improvements in our latest release of the H-Invitational Database (H-InvDB; http://www.h-invitational.jp/), a comprehensive annotation resource for human genes and transcripts. H-InvDB, originally developed as an integrated database of the human transcriptome based on extensive annotation of large sets of full-length cDNA (FLcDNA) clones, now provides annotation for 120 558 human mRNAs extracted from the International Nucleotide Sequence Databases (INSD), in addition to 54 978 human FLcDNAs, in the latest release H-InvDB_4.6. We mapped those human transcripts onto the human genome sequences (NCBI build 36.1) and determined 34 699 human gene clusters, which could define 34 057 (98.1%) protein-coding and 642 (1.9%) non-protein-coding loci; 858 (2.5%) transcribed loci overlapped with predicted pseudogenes. For all these transcripts and genes, we provide comprehensive annotation including gene structures, gene functions, alternative splicing variants, functional non-protein-coding RNAs, functional domains, predicted sub cellular localizations, metabolic pathways, predictions of protein 3D structure, mapping of SNPs and microsatellite repeat motifs, co-localization with orphan diseases, gene expression profiles, orthologous genes, protein-protein interactions (PPI) and annotation for gene families. The current H-InvDB annotation resources consist of two main views: Transcript view and Locus view and eight sub-databases: the DiseaseInfo Viewer, H-ANGEL, the Clustering Viewer, G-integra, the TOPO Viewer, Evola, the PPI view and the Gene family/group.
- Published
- 2008
47. Large-scale identification and characterization of alternative splicing variants of human gene transcripts using 56 419 completely sequenced and manually annotated full-length cDNAs
- Author
-
Takeda, J-I, Suzuki, Y., Nakao, M., Barrero, R.A., Koyanagi, K.O., Jin, L., Motono, C., Hata, H., Isogai, T., Nagai, K., Otsuki, T., Kuryshev, V., Shionyu, M., Yura, K., Go, M., Thierry-Mieg, J., Thierry-Mieg, D., Wiemann, S., Nomura, N., Sugano, S., Gojobori, T., Imanishi, T., Takeda, J-I, Suzuki, Y., Nakao, M., Barrero, R.A., Koyanagi, K.O., Jin, L., Motono, C., Hata, H., Isogai, T., Nagai, K., Otsuki, T., Kuryshev, V., Shionyu, M., Yura, K., Go, M., Thierry-Mieg, J., Thierry-Mieg, D., Wiemann, S., Nomura, N., Sugano, S., Gojobori, T., and Imanishi, T.
- Abstract
We report the first genome-wide identification and characterization of alternative splicing in human gene transcripts based on analysis of the full-length cDNAs. Applying both manual and computational analyses for 56 419 completely sequenced and precisely annotated full-length cDNAs selected for the H-Invitational human transcriptome annotation meetings, we identified 6877 alternative splicing genes with 18 297 different alternative splicing variants. A total of 37 670 exons were involved in these alternative splicing events. The encoded protein sequences were affected in 6005 of the 6877 genes. Notably, alternative splicing affected protein motifs in 3015 genes, subcellular localizations in 2982 genes and transmembrane domains in 1348 genes. We also identified interesting patterns of alternative splicing, in which two distinct genes seemed to be bridged, nested or having overlapping protein coding sequences (CDSs) of different reading frames (multiple CDS). In these cases, completely unrelated proteins are encoded by a single locus. Genome-wide annotations of alternative splicing, relying on full-length cDNAs, should lay firm groundwork for exploring in detail the diversification of protein function, which is mediated by the fast expanding universe of alternative splicing variants.
- Published
- 2006
48. Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis
- Author
-
Aguilar-Moncayo, M., primary, Takai, T., additional, Higaki, K., additional, Mena-Barragán, T., additional, Hirano, Y., additional, Yura, K., additional, Li, L., additional, Yu, Y., additional, Ninomiya, H., additional, García-Moreno, M. I., additional, Ishii, S., additional, Sakakibara, Y., additional, Ohno, K., additional, Nanba, E., additional, Ortiz Mellet, C., additional, García Fernández, J. M., additional, and Suzuki, Y., additional
- Published
- 2012
- Full Text
- View/download PDF
49. Serum thrombopoietin level and thrombocytopenia during the neonatal period in infants with Down's syndrome
- Author
-
Matsubara, K, primary, Nigami, H, additional, Yura, K, additional, Inoue, T, additional, Isome, K, additional, and Fukaya, T, additional
- Published
- 2009
- Full Text
- View/download PDF
50. Characteristics and Prediction of RNA Editing Sites in Transcripts of the Moss Takakia lepidozioides Chloroplast
- Author
-
Yura, K., primary, Miyata, Y., additional, Arikawa, T., additional, Higuchi, M., additional, and Sugita, M., additional
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.